Question 1

Am I eligible for this trial based on my current health and treatments?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Dose-escalation Pharmacokinetic Study of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and Patients With Normal Renal Function clinical trial (NCT01278758). Contact the study team or your healthcare provider for specific answers.

Question 2

How does ASA404 compare to my current treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Dose-escalation Pharmacokinetic Study of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and Patients With Normal Renal Function clinical trial (NCT01278758). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential side effects of ASA404?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Dose-escalation Pharmacokinetic Study of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and Patients With Normal Renal Function clinical trial (NCT01278758). Contact the study team or your healthcare provider for specific answers.

Question 4

How will my kidney function affect my treatment with ASA404?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Dose-escalation Pharmacokinetic Study of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and Patients With Normal Renal Function clinical trial (NCT01278758). Contact the study team or your healthcare provider for specific answers.

Question 5

What kind of monitoring will I need during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Dose-escalation Pharmacokinetic Study of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and Patients With Normal Renal Function clinical trial (NCT01278758). Contact the study team or your healthcare provider for specific answers.

Question 6

Where will the trial visits take place, and how often will I need to go?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Dose-escalation Pharmacokinetic Study of Intravenous ASA404 in Adult Advanced Cancer Patients With Impaired Renal Function and Patients With Normal Renal Function clinical trial (NCT01278758). Contact the study team or your healthcare provider for specific answers.

What this study is about